Arbutus Intangible Assets from 2010 to 2024

ABUS Stock  USD 3.76  0.08  2.17%   
Arbutus Biopharma Intangible Assets yearly trend continues to be comparatively stable with very little volatility. Intangible Assets will likely drop to about 35.2 M in 2024. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2000-03-31
Previous Quarter
43.8 M
Current Value
43.8 M
Quarterly Volatility
94 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Arbutus Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arbutus Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 701.5 K or Selling General Administrative of 12.2 M, as well as many indicators such as Price To Sales Ratio of 13.01, Dividend Yield of 0.0529 or PTB Ratio of 3.72. Arbutus financial statements analysis is a perfect complement when working with Arbutus Biopharma Valuation or Volatility modules.
  
Check out the analysis of Arbutus Biopharma Correlation against competitors.

Latest Arbutus Biopharma's Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Arbutus Biopharma Corp over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Arbutus Biopharma's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arbutus Biopharma's overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Very volatile
   Intangible Assets   
       Timeline  

Arbutus Intangible Assets Regression Statistics

Arithmetic Mean54,350,500
Geometric Mean0.00
Coefficient Of Variation160.65
Mean Deviation46,345,400
Median43,800,000
Standard Deviation87,314,141
Sample Variance7623.8T
Range352.6M
R-Value0.07
Mean Square Error8166T
R-Squared0.01
Significance0.79
Slope1,433,052
Total Sum of Squares106732.6T

Arbutus Intangible Assets History

202435.2 M
202350.4 M
201843.8 M
201758.6 M
201699.4 M
2015352.6 M

About Arbutus Biopharma Financial Statements

Arbutus Biopharma shareholders use historical fundamental indicators, such as Intangible Assets, to determine how well the company is positioned to perform in the future. Although Arbutus Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Arbutus Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Arbutus Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Intangible Assets50.4 M35.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arbutus Stock Analysis

When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.